Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Bienaime Jean Jacques
Relationship:  
City:   Palo Alto
State:   CA
   
Insider Summary:
  
   
Companies Owned :   8    
Direct Shares   540,054    

Indirect Shares

   247,533      
Direct Value   $43,092,104    

Indirect Value

   $21,938,850      
Total Shares   787,587      
Total Value   $65,030,954      


Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $914,552 Immunome Inc. $149,513 Keros Therapeutics, Inc. $0 Biomarin Pharmaceutical Inc $41,992,185 Neurogesx Inc $0 Portola Pharmaceuticals Inc $12,729 Immunic Inc $23,125 Incyte Corp $914,552 Immunome Inc. $149,513 Keros Therapeutics, Inc. $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    2   
    1    

     Stock price went up :
    1   
    0    
     Stock price went down :
    1   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
   -13.1%
 -5.5%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Biomarin Pharmaceutical Inc BMRN Director 2024-05-20 473,792 2024-05-20 247,533    Premium*  
            Neurogesx Inc NGSX Director 2011-07-26 21,748 0    Premium*  
            InterMune Inc ITMN Director 2014-09-29 0 2012-04-06 0    Premium*  
            Portola Pharmaceuticals Inc PTLA Director 2014-05-16 706 2013-05-28 0    Premium*  
            Immunic Inc IMUX Director 2018-09-24 18,500 2001-04-23 0    Premium*  
            Incyte Corp INCY Director 2023-06-14 15,493 0    Premium*  
            Immunome Inc. IMNM 2024-05-21 9,615 0    Premium*  
            Keros Therapeutics, Inc. KROS 2024-06-01 200 0    Premium*  
* Premium Members only  

Records found :    853         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 32 of 35
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2019-03-22 4 D $88.05 $1,155,832 D/D (13,127) 323,211 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-03-10 4 AS $77.57 $1,163,550 D/D (15,000) 338,569 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-03-11 4 AS $77.81 $1,167,150 D/D (15,000) 338,569 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-03-15 4 D $83.57 $1,245,862 D/D (14,908) 249,766 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-03-16 4 AS $83.26 $1,248,854 D/D (15,000) 296,106 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-04-11 4 OE $63.10 $1,262,000 D/D 20,000 494,994 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-04-12 4 OE $63.10 $1,262,000 D/D 20,000 494,994 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-05-09 4 OE $63.10 $1,262,000 D/D 20,000 494,994 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-05-10 4 OE $63.10 $1,262,000 D/D 20,000 494,994 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-03-15 4 AS $84.73 $1,270,901 D/D (15,000) 264,674 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-02-09 4 AS $88.28 $1,324,200 D/D (15,000) 419,602 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-02-08 4 AS $89.77 $1,346,550 D/D (15,000) 419,602 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-03-10 4 AS $92.28 $1,384,200 D/D (15,000) 487,856 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2017-03-15 4 D $92.50 $1,451,325 D/D (15,690) 190,674 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-11-07 4 OE $21.51 $1,505,700 D/D 70,000 393,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2016-11-08 4 OE $21.51 $1,505,700 D/D 70,000 393,368 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-05-06 4 AS $81.00 $1,620,000 D/D (20,000) 335,324 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-05-10 4 AS $81.14 $1,622,800 D/D (20,000) 474,994 0 -
BMRN Biomarin Pharmaceutical I... Director   –       •      –    2024-05-09 4 AS $81.62 $1,632,400 D/D (20,000) 474,994 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2022-04-18 4 AS $81.91 $1,638,200 D/D (20,000) 334,983 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2023-02-10 4 AS $110.11 $1,651,650 D/D (15,000) 320,324 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-15 4 AS $88.29 $1,655,434 D/D (18,750) 290,600 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-11 4 AS $88.42 $1,657,856 D/D (18,750) 290,600 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-17 4 AS $88.66 $1,662,356 D/D (18,750) 290,600 0 -
BMRN Biomarin Pharmaceutical I... Chief Executive Officer   •       •      –    2018-05-16 4 AS $89.13 $1,671,131 D/D (18,750) 290,600 0 -
  853  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29   30   31   32  33   34   35      
  Page 32 of 35  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us